Skip to main content
. 2016 May 30;5:7–14. doi: 10.1016/j.jcte.2016.05.004

Figure 3.

Figure 3

Peripheral quantitative computed tomography (pQCT) images of the 38% tibia, unaffected site at baseline, 8 and 12 weeks between teriparatide and placebo groups. Treatment was administered from baseline to 8 weeks. * Indicates = 0.05, between groups. ** Indicates = 0.05 within groups, over time.